Korea VHD Echo Study: Surveillance of Aortic, Mitral & Tricuspid Patients - Insights From Real-world Practice

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with moderate or severe disease of their own heart valves. It looks back at records and heart ultrasound scans from 2010.1.1 to 2020.12.31.

Életkor

Older than 18 years (from 19 Years).

Nem

All sexes can join.

A betegség stádiuma

Moderate or severe disease of the person's own (native) heart valve: narrowing of the aortic valve (AS), leaking aortic valve (AR), leaking mitral valve (MR) or leaking tricuspid valve (TR).

Korábbi kezelés

People must have had a heart ultrasound (echocardiography) more than twice.

A részvétel fő kizáró okai

• Poor quality heart ultrasound images
• Lost to follow-up

A regiszter feltételei, szó szerint

Mit akar kideríteni a vizsgálat

Valvular heart disease (VHD) is a growing public health concern globally, with increasing disease burden and rising interest in advanced treatment strategies such as transcatheter interventions. However, there remains a significant lack of real-world data regarding echocardiography practices, disease prevalence and progression, referral patterns, and treatment pathways. Addressing these gaps is critical for improving patient care and informing clinical decision-making.

A vizsgálat 3 csoportja

• Aortic petients

  Primary focus is aortic stenosis patients; secondary focus is aortic regurgitation.

• Mitral Patients

  Primary focus is Degenerative Mitral Regurgitation patients; secondary focus is Functional Mitral Regurgitation.

• Tricuspid Patients

  Primary focus is Tircuspid Regurgitation patients